Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Nov. 26, 2021	Nov. 27, 2020
Cash flows from operating activities:
Net income	$ 20,698	$ 2,027
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation expense and amortization of intangible assets	15,813	8,367
Amortization of debt discounts and issuance costs	2,332	2,116
Share-based compensation expense	9,775	11,088
Change in fair value of contingent consideration	17,200
Amortization of operating lease right-of-use assets	2,548	1,413
Other	(192)	(14)
Changes in operating assets and liabilities:
Accounts receivable	(36,053)	(1,930)
Inventories	39,640	12,919
Other current assets	(932)	(9,277)
Accounts payable and accrued expenses	(53,751)	10,142
Operating lease liabilities	(2,141)	(1,504)
Deferred income taxes, net	209	222
Net cash provided by operating activities	15,146	35,569
Cash flows from investing activities:
Capital expenditures and deposits on equipment	(12,766)	(14,644)
Other	(611)	16
Net cash used for investing activities	(13,377)	(14,628)
Cash flows from financing activities:
Proceeds from borrowing under line of credit	60,000	19,500
Proceeds from issuance of ordinary shares	5,029	3,105
Repayments of borrowings under line of credit	(50,000)	(19,500)
Payments to acquire ordinary shares	(2,666)	(3,483)
Net cash provided by (used for) financing activities	12,363	(378)
Effect of changes in currency exchange rates on cash and cash equivalents	(4,068)	(7,277)
Net increase in cash and cash equivalents	10,064	13,286
Cash and cash equivalents at beginning of period	222,986	150,811
Cash and cash equivalents at end of period	$ 233,050	$ 164,097